U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07323654) titled 'A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma' on Jan. 06.
Brief Summary: This Phase 2b study is designed to evaluate the safety and efficacy of KT-621 in participants with uncontrolled moderate to severe eosinophilic asthma.
The main goals of this study are to investigate how effective KT-621 is at treating uncontrolled moderate to severe eosinophilic asthma, the safety and tolerability of KT-621, and how KT-621 behaves in the body.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Eosinophilic Asthma
Intervention:
DRUG: KT-621
Oral drug
OTHER: Plac...